Eventhum Orthopaedics, a Leeds, UK-based medtech company developing devices for the knee replacement surgery, raised £3.8M in funding.
The round was led by NPIF II – Mercia Equity Finance, Mercia’s EIS funds and private investors including.
The company intends to use the funds to build stocks of its product following its launch in the UK, US and New Zealand and to develop two new devices.
Led by CEO and Founder John Naybour, Eventum provides the QuadSense device that helps surgeons to precisely cut and place the kneecap in total knee replacements. QuadSense has already gained regulatory approvals in the UK and US and been used in over 300 procedures. The company has now appointed distributors in both countries and in a number of other key international markets, and it is developing similar devices for shoulder and hip operations.
The latest funding round was the third led by Mercia Ventures and NPIF and brought the total raised by the company to over £7m.
FinSMEs
18/03/2025